This Week in Health CareSM, September 2, 2015
Every Wednesday, Stateside Associates selects some health care-related state and local events to highlight in This Week in Health Care.
To provide feedback, or for more information about these issues or Stateside Associates’ Health Care Practice, please contact Robert Holden at (703) 525-7466 or firstname.lastname@example.org.
The Medicaid Agency will accept comments until September 4 regarding proposed amendments to a rule concerning the preferred drug list. Becky Lukaesko at email@example.com
The Composite Medical Board will hold a public hearing September 3 regarding proposed amendments to a rule concerning vaccine protocol agreements. Becky Lukaesko at firstname.lastname@example.org
The Joint Committee on Behavioral Health and Opioid Use Disorders will meet September 9 to discuss oversight of the prescription drug monitoring program as well as the state and local programs designed to treat and reduce behavioral health disorders. Patrick Gallaher at email@example.com
The Board of Dentistry will hold a public hearing September 3 regarding proposed amendments to rules concerning licensure. Becky Lukaesko at firstname.lastname@example.org
The Board of Pharmacy is holding a workshop September 2 regarding possible amendments to the schedule of controlled substances. Stefanie Frank at email@example.com
The House Health, Human Services and Elderly Affairs Committee will meet September 8 for a subcommittee work session regarding the recently enacted S.B. 7, which directs the committee to provide legislative oversight, policy direction and recommendations for legislation related to managed care in the state. Zeynab Abdul at firstname.lastname@example.org
The Health Insurance Reform Commission will meet September 8 to discuss health care reform. The Commission will discuss the implementation of the Patient Protection and Affordable Care Act, including amendments and regulations promulgated under the Act. Zeynab Abdul at email@example.com
The Office of the Insurance Commissioner will hold a public hearing September 9 regarding essential health benefits designation and supplementation for the year 2017. Rebecca Kelly at firstname.lastname@example.org
The Joint Corporations, Elections and Political Subdivisions Interim Committee will meet September 8-9 to discuss pharmacy benefit managers and auditing procedures. The Committee intends to draft legislation establishing provisions for the regulation of audits conducted by pharmacy benefit managers on pharmacies and will also address the regulation of maximum allowable cost pricing. Zeynab Abdul at email@example.com